IBT
International Biotechnology Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $7.28M | Sell |
8,847
-18,153
| -67% | -$14.9M | 2.45% | 16 |
|
|
2023
Q2 | $19.4M | Buy |
27,000
+15,800
| +141% | +$11.4M | 5.91% | 4 |
|
|
2023
Q1 | $9.2M | Hold |
11,200
| – | – | 2.57% | 13 |
|
|
2022
Q4 | $8.08M | Hold |
11,200
| – | – | 2.5% | 14 |
|
|
2022
Q3 | $7.72M | Sell |
11,200
-2,810
| -20% | -$1.94M | 2.47% | 13 |
|
|
2022
Q2 | $23.7K | Buy |
14,010
+1,910
| +16% | +$3.23K | 0.25% | 61 |
|
|
2022
Q1 | $2.25M | Hold |
12,100
| – | – | 0.51% | 41 |
|
|
2021
Q4 | $7.64M | Buy |
12,100
+4,400
| +57% | +$2.78M | 1.7% | 23 |
|
|
2021
Q3 | $4.66M | Sell |
7,700
-29,500
| -79% | -$17.8M | 1.12% | 26 |
|
|
2021
Q2 | $20.8M | Sell |
37,200
-6,600
| -15% | -$3.69M | 5.49% | 5 |
|
|
2021
Q1 | $20.7M | Buy |
43,800
+32,300
| +281% | +$15.3M | 5.48% | 3 |
|
|
2020
Q4 | $5.55M | Hold |
11,500
| – | – | 1.52% | 19 |
|
|
2020
Q3 | $6.43M | Hold |
11,500
| – | – | 2.08% | 18 |
|
|
2020
Q2 | $7.02M | Buy |
+11,500
| New | +$7.02M | 2.33% | 17 |
|
|
2020
Q1 | – | Sell |
-28,830
| Closed | -$10.8M | – | 62 |
|
|
2019
Q4 | $10.8M | Sell |
28,830
-11,000
| -28% | -$4.13M | 3.9% | 8 |
|
|
2019
Q3 | $11.1M | Buy |
39,830
+16,500
| +71% | +$4.58M | 5.11% | 6 |
|
|
2019
Q2 | $7.3M | Sell |
23,330
-8,300
| -26% | -$2.6M | 2.71% | 14 |
|
|
2019
Q1 | $13M | Buy |
31,630
+300
| +1% | +$123K | 4.8% | 3 |
|
|
2018
Q4 | $9.19M | Hold |
31,330
| – | – | 5.7% | 5 |
|
|
2018
Q3 | $9.71M | Hold |
31,330
| – | – | 4.61% | 6 |
|
|
2018
Q2 | $10.8M | Sell |
31,330
-4,700
| -13% | -$1.62M | 4.15% | 6 |
|
|
2018
Q1 | $12.4M | Sell |
36,030
-4,800
| -12% | -$1.65M | 4.84% | 6 |
|
|
2017
Q4 | $15.4M | Hold |
40,830
| – | – | 5.41% | 3 |
|
|
2017
Q3 | $18.3M | Sell |
40,830
-7,300
| -15% | -$3.26M | 7.11% | 3 |
|
|
2017
Q2 | $23.6M | Buy |
48,130
+3,000
| +7% | +$1.47M | 8.98% | 1 |
|
|
2017
Q1 | $17.5M | Buy |
45,130
+12,700
| +39% | +$4.92M | 6.69% | 3 |
|
|
2016
Q4 | $11.9M | Buy |
+32,430
| New | +$11.9M | 5.37% | 7 |
|